Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE

M. Wechsler (Denver, United States of America), L. Ford (Bellevue, United States of America), J. Maspero (Buenos Aires, Argentina), I. Pavord (Oxford, United Kingdom), Y. Tohda (Osakasayama, Osaka, Japan), D. Langton (Frankston, Australia), C. Domingo (Sabadell, Barcelona, Spain), A. Papi (Ferrara, Italy), A. Bourdin (Montpellier, France), H. Watz (Grosshansdorf, Germany), H. Park (Suwon, Republic of Korea), K. Chapman (Toronto, Canada), X. Mao (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), M. Djandji (Cambridge, United States of America), U. Kapoor (Bridgewater, United States of America), F. Khokhar (Tarrytown, United States of America), L. Mannent (Chilly-Mazarin, France), M. Ruddy (Tarrytown, United States of America), E. Laws (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Hardin (Cambridge, United States of America)

Source: Virtual Congress 2020 – ALERT: Asthma in adults and children
Session: ALERT: Asthma in adults and children
Session type: Clinical trials session
Number: 4613

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wechsler (Denver, United States of America), L. Ford (Bellevue, United States of America), J. Maspero (Buenos Aires, Argentina), I. Pavord (Oxford, United Kingdom), Y. Tohda (Osakasayama, Osaka, Japan), D. Langton (Frankston, Australia), C. Domingo (Sabadell, Barcelona, Spain), A. Papi (Ferrara, Italy), A. Bourdin (Montpellier, France), H. Watz (Grosshansdorf, Germany), H. Park (Suwon, Republic of Korea), K. Chapman (Toronto, Canada), X. Mao (Bridgewater, United States of America), B. Ortiz (Tarrytown, United States of America), M. Djandji (Cambridge, United States of America), U. Kapoor (Bridgewater, United States of America), F. Khokhar (Tarrytown, United States of America), L. Mannent (Chilly-Mazarin, France), M. Ruddy (Tarrytown, United States of America), E. Laws (Bridgewater, United States of America), N. Amin (Tarrytown, United States of America), M. Hardin (Cambridge, United States of America). Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE. 4613

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: